AUSTIN, Texas, Feb. 26, 2026 /PRNewswire/ -- T ruemed, the leading HSA/FSA marketplace for top preventive health products, today announced it has received independent certification from the Validation ...

Hello, and thank you for standing by. At this time, I would like to welcome everyone to the CareDx Investor Webinar Call. [Operator Instructions] I would now like to turn the conference over to ...

Ultra‑Sensitive, Non‑Invasive Surveillance Solution Expected to Launch Commercially in the U.S. in 2027 as Part of CareDx’s Transplant+ Precision Medicine Portfolio CareDx, Inc. (Nasdaq: CDNA) — The ...

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of ...

We may receive a commission on purchases made from links. For the inexperienced crafter, pulling together a wreath for the front door might be dependent upon what's available at arts and craft stores ...

Health care leaders may want to keep a closer eye on clinical validation for artificial intelligence (AI)-enabled medical devices (AIMDs), based on a recent JAMA Health Forum study. The study examined ...

For any document version listed below, click on its file name to view it. The current [ ] version of the document is downloaded by default when the document is referenced elsewhere on the site.

Copyright: © 2025 The Author(s). Published by Elsevier Ltd.

Artificial intelligence-enabled medical devices with no clinical validation were more likely to be the subject of recalls, according to a study published in JAMA Health Forum. The study, published on ...